REGENMATRIX
LIVE

Serial Number

97858672

Owner

RegenLab USA LLC

Attorney

Lindsay Kaplan

Filing Date

Mar 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

REGENMATRIX Trademark

Serial Number: 97858672

REGENMATRIX is a trademark filed by RegenLab USA LLC on March 27, 2023. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

RegenLab USA LLC (60 trademarks)

95 Greene Street

Entity Type: 16

Trademark Details

Filing Date

March 27, 2023

Registration Date

Not Registered

Published for Opposition

June 4, 2024

Goods & Services

Surgical apparatus and instruments for medical, dental or veterinary use; surgical and medical apparatus and instruments for use in dentistry, orthopedics, cosmetics, esthetics, general surgery, ophthalmology and mesotherapy; surgical and medical apparatus and instruments for use in cardiovascular, esthetic, cardiac, thoracic, transplantation, head and neck, oral, bone, cartilage, tendon, implant, gastrointestinal, orthopedic, neurosurgical, facial, face-lift and plastic surgery; suture material; syringes for injections; cases fitted for medical instruments; receptacles for applying medicines, namely, bottles, jars, containers, canuale, syringes, tubes, infusion and injection devices for administering drugs, platelet-rich plasma, hyaluronic acid, and hydrogels; medical tubing for administering drugs, platelet-rich plasma, hyaluronic acid and hydrogels; syringes for medical use; cases fitted for medical instruments for use by surgeons or doctors; medical injection instruments with needles; medical injection instruments without needles; medical instruments, namely, surgical instruments for facilitating the identification, separation or removal of biological tissue; surgical and medical apparatus and instruments used in general surgery; medical apparatus used for taking blood; medical apparatus used for taking blood samples; apparatus used for separating blood components for medical purposes; medical instruments used for filtering blood and blood components; medical apparatus used for introducing pharmaceutical preparations into the human body; medical instruments, namely, surgical instruments for biological tissue; medical devices, namely, surgical instruments for biological tissues; medical apparatus intended for the preparation of platelet concentrate, glycosaminoglycan and polysaccharide hydrogels; all the foregoing relating to the use of blood derived ingredients in regenerative therapies.

Cosmetics, namely, beauty masks, cosmetic kits comprising primarily of lotions, creams, and preparations for skin care, cosmetic creams, lotions for cosmetic purposes, cosmetic lotions, cosmetic preparations for skin care, pomades for cosmetic purposes, tissues impregnated with cosmetic lotions, cotton buds for cosmetic purposes, cosmetic kits for skin care comprising primarily of lotions, creams, and preparations for skin care, non-medicated preparations for skin care, namely, skin serum not for medical use, skin care preparations, namely, non-medicated skin serum, non-medicated stimulating lotions for the skin, anti-wrinkle cream for skin care, non-medicated anti-aging serum

Pharmaceutical and veterinary preparations, namely, solutions for application on and under tissue, bone and organ for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontum growth and bone, organ or tissue regeneration; sanitary preparations for medical purposes; adjuvants for medical purposes; biological preparations for the treatment of musculoskeletal, skin, urological and urogenital diseases and conditions, arthritis, and wound care; pharmaceutical skin lotions; tissues impregnated with pharmaceutical lotions for medical purposes; medical dressings; surgical cloth tissues; medicated skin care preparations; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; preparations for medical purposes for cleaning the skin; solution kits for reconstituting allograft tissue; cells for medical or clinical purposes; all-purpose disinfectants; disinfectants for hygiene purposes; kits containing chemical reagents used for medical diagnosis; plant extracts, and human and animal tissue and cells in the nature of cultures, grafts and fresh cells, for medical and veterinary use; all the foregoing relating to the use of blood derived ingredients in regenerative therapies.

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 27, 2026 EXRA
SOU EXTENSION 3 GRANTED
May 26, 2026 EX3G
SOU EXTENSION 3 FILED
May 26, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
May 26, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 25, 2025 EXRA
SOU EXTENSION 2 GRANTED
Nov 24, 2025 EX2G
SOU EXTENSION 2 FILED
Nov 24, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 24, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 13, 2025 EXRA
SOU EXTENSION 1 GRANTED
Mar 12, 2025 EX1G
SOU EXTENSION 1 FILED
Mar 12, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 12, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 26, 2024 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Oct 13, 2024 ETOP
POST PUBLICATION AMENDMENT - ENTERED
Sep 11, 2024 CHPB
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 5, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 5, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 5, 2024 COAR
ASSIGNED TO PETITION STAFF
Sep 3, 2024 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Aug 21, 2024 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 20, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 4, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 4, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 15, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 1, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
May 1, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 1, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
May 1, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 1, 2024 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 19, 2024 GNFN
FINAL REFUSAL E-MAILED
Apr 19, 2024 GNFR
FINAL REFUSAL WRITTEN
Apr 19, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 22, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 22, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 22, 2024 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 6, 2024 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 30, 2024 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 18, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 18, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 18, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 18, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 18, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 4, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 4, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 4, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 20, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 18, 2023 NWOS
NEW APPLICATION ENTERED
Mar 30, 2023 NWAP